Selective Precision Targeting (SPoT)
Agency: National Institutes of Health
- 93.350 -- National Center for Advancing Translational Sciences
Forecasted opportunityLast Updated: May 13, 2026
Important dates
- Forecasted post date: December 15, 2025
- Forecasted application due date: February 17, 2026
- Forecasted award date: December 17, 2026
- Forecasted project start date: January 18, 2027
- Fiscal Year: 2028
Award details
- Expected project funding: $1,500,000
- Expected awards: 5
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:FOR-TR-27-003
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: June 27, 2025
- Archive date: Not specified
- Version: 1
Summary
The National Center for Advancing Translational Science (NCATS) seeks to advance its mission by establishing a new initiative called Selective Precision Targeting (SPoT) to determine a mechanism for precise and on-target therapeutic drug delivery to specific hard-to-reach locations within the human body using microphysiological systems (MPS). Targeted drug-delivery systems, including engineered nanoparticles, extracellular vesicles or focused ultrasound, are methods for delivering medications to a specific area of the body (organ, tissue, or cell) to increase the concentration of the drug in that area. Hard-to-reach locations in the body include the blood–brain barrier, central nervous system, placenta, retina, or a tumor.
More specifically, the initiative goals are to:
- Optimize specific targeting of nanoparticle therapeutics to the target organ/cell of interest
- Assess biodistribution and off-target effects using a multi-organ microphysiological system
- Provide evidence of functional cargo activity
- Determine optimal route of administration
Grant authorities that allow the National Center for Advancing Translational Science (NCATS) to forecast this opportunity are as follows: 42 U.S. Code § 287a - Cures Acceleration Network.
Eligibility
Education
- Public and state institutions of higher education
- Private institutions of higher education
- Independent school districts
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
Government
- Federally recognized Native American tribal governments
- County governments
- Public and Indian housing authorities
- State governments
Business
- For-profit organizations other than small businesses
- Small businesses
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: passley.hargrove@nih.gov
passley.hargrove@nih.gov
Link to additional information
No additional information is available
